TxSUS Sessions
TxSUS Sessions are live webinars with expert speakers discussing key issues at the intersection of policy and practice. The goal of these sessions is to promote awareness, engagement, and support for innovative projects addressing substance use in Texas.
Upcoming TxSUS Sessions:
Coming Soon
Fentanyl: Fuel on the Policy Fire
Balancing Public Health and Criminal Justice Responses to SUD
Thursday, August 31 @ 12 – 1 p.m. CST
Learning Objectives:
- Discuss how fentanyl concerns are impacting policy responses.
- Differentiate between evidence-based policy interventions and sensationalized, non-evidence-based interventions.
- Explain common media missteps regarding fentanyl, such as misunderstanding of fentanyl’s pharmacological properties or naloxone’s effectiveness.
August Speaker:
Morgan Godvin
Research Associate
Action Lab – Center for Health Policy & Law
Northeastern University
1 CEU will be awarded for CPE, CME, CNE and SWs.
Past Sessions:
Fentanyl: Fuel on the Policy Fire
Balancing Public Health and Criminal Justice Responses to SUD
August 31, 2023
Morgan Godvin
Research Associate
Action Lab – Center for Health Policy & Law
Northeastern University
2023 Texas Substance Use Symposium
March 27-28, 2023
The following sessions were recorded at TxSUS 2023 in San Antonio, Texas:
- Buprenorphine Induction Strategies in the Age of Fentanyl – Tirado
- The Other MAT: Medications for Alcohol and Stimulant Use Disorders -Wakhlu
- Treatment for Substance Use Disorders in Youth – Ramamurthy
- Stigma Kills – Addressing Opioid and Substance Use Disorder by Changing Health System Culture – Bottner
Claim home study CE credit for viewing any of the above recorded sessions
2023 CDC Guideline for Prescribing Opioids for Pain
February 15, 2022
Stefan Kertesz, MD
Professor,
The University of Alabama Marnix E. Heersink School of Medicine
Opportunities & Challenges in Telehealth for Substance Use Disorder
December 9, 2022
Carlos F. Tirado, MD, MPH, FASAM
Chief Medical Officer,
CARMAHealth
Lesley Mason, PsyD
Clinical Associate Professor,
Arizona State University
Jennifer Sharpe Potter, PhD, MPH
Executive Director,
Be Well Texas
Exploring Sustainable Funding Models for Substance Use Disorder Treatment and Recovery
July 20, 2022
Karla Ramirez, LCSW, MSSW, MSHA
Director, Be Well Texas
UT Health San Antonio
The Real & Imagined Risks of Novel Synthetic Drugs
February 8, 2022
Claire M. Zagorski, MSc, LP
Program Coordinator, PhARM
College of Pharmacy
The University of Texas at Austin
Lucas G. Hill, PharmD, BCACP
Director, The University of Texas at Austin PhARM Program
The Technology Dilemma: Can Technology Fix the Overdose Crisis?
December 1, 2021
Kasey Claborn, PhD
Assistant Professor
The University of Texas
at Austin
Steve Hicks School of
Social Work
Daniela Luzi Tudor
Co-Founder and CEO,
WEconnect
Claire M. Zagorski, MSc, LP
Program Coordinator, PhARM
College of Pharmacy
The University of Texas at Austin
Mobile Methadone: Policy Implications and Notes from the Field
September 29, 2021
Corey Davis, JD, MSPH, EMT
Director, Harm Reduction Legal Project,
Deputy Director, Southeastern Region
Sean Soth
Director of Health and Integration
Evergreen Treatment Services
Catherine Perez
Director of Strategic Initiatives
Evergreen Treatment Services
